94 Solaris Avenue
Camana Bay KY1-1108
Cayman Islands
345-949-4123
https://www.beigene.com
Setor(es): Healthcare
Indústria: Biotechnology
Funcionários Integrais: 10.600
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. John V. Oyler | Co-Founder, Executive Chairman & CEO | 12,31M | N/A | 1968 |
Dr. Xiaobin Wu Ph.D. | President & COO | 8,63M | N/A | 1962 |
Dr. Xiaodong Wang Ph.D. | Co-Chairman of Scientific Advisory Board & Non-Executive Director and Co-Founder | 22,41M | N/A | 1963 |
Ms. Julia Wang | CFO & Principal Financial Officer | 5,41M | N/A | 1971 |
Mr. Chan Lee | General Counsel & Senior VP | 5,11M | N/A | 1968 |
Mr. Wang Lai Ph.D. | Global Head of R&D | 5,67M | N/A | 1977 |
Mr. Titus B. Ball | VP & Chief Accounting Officer | N/A | N/A | 1973 |
Ms. Liza Heapes | Head of Investor Relations | N/A | N/A | N/A |
Mr. Yang Ji | Chief Compliance Officer | N/A | N/A | N/A |
Dr. Yan Qi | Senior VP & Head of Public Affairs - Greater China | N/A | N/A | N/A |
O QualityScore de governança da ISS da BeiGene, Ltd. a partir de 1 de maio de 2024 é 8. As principais pontuações para Auditoria são: 9; Conselho: 5; Direitos de Acionistas: 6; Compensação: 10.